STOCK TITAN

Quanome Technologies Q1 revenue rises 53% to $2.05M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Quanome Technologies, Inc. (QNME) reported fiscal first-quarter results for the period ended September 30, 2026. Revenue was US$2.05 million, up 53% year over year, and gross profit doubled to US$1.10 million, primarily reflecting higher supplier rebates. Its pharmaceutical distribution business continued to provide revenue, while XDT remained pre-revenue at quarter-end.

During the quarter, Quanome agreed to purchase 32 NVIDIA-powered GPU servers for approximately US$18.8 million for XDT’s first U.S. AI inference hub. A September 29, 2026 agreement to buy a further 32 brought the total under purchase agreements to 64. XDT’s first enterprise customer agreement has an initial order commitment exceeding US$100 million over 60 months from the service-ready date, subject to contractual service-start conditions. Quanome received a US$13.5 million prepayment toward future services on October 29, 2026. Management anticipates initial XDT service revenue in fiscal 2027’s second or third quarter, subject to successful deployment and the service-start conditions.

Separately, Quanome agreed to acquire approximately 5% of QAI Labs at closing through an all-stock agreement.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointQuarterly revenue increased 53% year over year to US$2.05 million.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Quarterly revenue US$2.05 million Fiscal first quarter ended September 30, 2026; increased 53% year over year.
Gross profit US$1.10 million Fiscal first quarter ended September 30, 2026; doubled, primarily reflecting higher supplier rebates.
GPU server purchase agreement Approximately US$18.8 million Agreement to purchase 32 NVIDIA-powered GPU servers for XDT’s first U.S. AI inference hub.
GPU servers under purchase agreements 64 GPU servers Includes the further 32-server purchase agreement dated September 29, 2026.
Initial customer order commitment Exceeding US$100 million XDT agreement; subject to contractual service-start conditions.
Customer order term 60 months Begins on the service-ready date.
Prepayment received US$13.5 million Received October 29, 2026, toward future services.
QAI Labs stake agreed Approximately 5% All-stock agreement to acquire the stake at closing.
AI inference hub technical
"XDT’s first U.S. AI inference hub"
pre-revenue financial
"XDT remained pre-revenue at quarter-end"
service-ready date technical
"60 months from the service-ready date"
service-start conditions technical
"subject to contractual service-start conditions"
all-stock agreement financial
"agreed to acquire approximately 5% of QAI Labs at closing through an all-stock agreement"
supplier rebates financial
"primarily reflecting higher supplier rebates"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were QNME’s fiscal first-quarter revenue and gross profit?

Quanome reported revenue of US$2.05 million and gross profit of US$1.10 million for the fiscal quarter ended September 30, 2026. Revenue increased 53% year over year, while gross profit doubled, primarily reflecting higher supplier rebates. XDT remained pre-revenue at quarter-end.

How large is QNME’s first AI inference customer order?

XDT’s initial customer order commitment exceeds US$100 million over a 60-month term beginning on the service-ready date, subject to contractual service-start conditions. Quanome received a US$13.5 million prepayment toward future services on October 29, 2026.

When does QNME expect its first XDT service revenue?

Management anticipates initial XDT service revenue in the second or third quarter of fiscal 2027, subject to successful deployment and satisfaction of the service-start conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001996192 0001996192 2026-11-17 2026-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 17, 2026

 

Quanome Technologies, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-42140   82-1978491
(State or other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

112 W 34th St, FL 18, Room 18022
New York, NY
  10120
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (778) 888-7232

 

Not Applicable

(Former name or former address if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of Each Exchange on Which Registered
Common Stock, $0.0001 par value per share   QNME   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On November 17, 2026, the Company issued a press release titled “Quanome Reports Fiscal First-Quarter Results: First quarter establishes foundation for first enterprise customer agreement and US$13.5 million prepayment for dedicated AI inference services.” A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

 

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit
Number
  Description
99.1   Press release, issued on November 17, 2026
104   Cover Page Interactive Data File (formatted in iXBRL, and included in exhibit 101)

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Quanome Technologies, Inc.
   
Dated: November 17, 2026 By: /s/ Yang Li
  Name: Yang Li
  Title: Chief Executive Officer and Director

 

2

 

Exhibit 99.1

 

Quanome Reports Fiscal First-Quarter Results

 

First quarter establishes foundation for first enterprise customer agreement

 

and US$13.5 million prepayment for dedicated AI inference services

 

NEW YORK, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Quanome Technologies, Inc. (Nasdaq: QNME, “Quanome”) today reported results for the fiscal first quarter ended September 30, 2026, and provided an update on its AI computing business. During the quarter, Quanome entered into an approximately US$18.8 million agreement to purchase 32 NVIDIA-powered GPU servers for the first U.S. AI inference hub of XDT Infrastructure I, LLC (“XDT”), its indirect wholly owned subsidiary.

 

“This first quarter represents a critical milestone in the launch of Quanome as a business focused on quantum and AI opportunities,” commented Mr. Yang Li, Chief Executive Officer of Quanome Technologies. “Our business pivot led to our first enterprise customer agreement, with an initial order commitment exceeding US$100 million over a five-year term, subject to contractual service-start conditions. Following quarter-end, we received a US$13.5 million prepayment toward future services. It is important for shareholders to recognize the momentum we established in the first quarter that is now supporting our progress toward service commencement.”

 

Results of Operations & Operational Update

 

Quanome’s established pharmaceutical distribution business, Hupan Pharmaceutical (Hubei) Co., Ltd (“Hupan Pharmaceutical,” and, together with Quanome, XDT and Quanome’s other subsidiaries, the “Group”), continued to provide the Group’s revenue base as XDT prepared to launch services. Quarterly revenue increased 53% year over year to US$2.05 million. Gross profit doubled to US$1.10 million, primarily reflecting higher supplier rebates.

 

XDT remained pre-revenue at quarter-end. The hub is designed to give enterprise customers dedicated capacity to run AI models on infrastructure that the Group owns and operates.

 

Following quarter-end, Quanome announced further developments across its quantum and AI strategy. During the first quarter of fiscal 2027, XDT secured its first enterprise customer agreement and subsequently received, on October 29, 2026, a US$13.5 million prepayment toward future services. The initial order has a total commitment value exceeding US$100 million over a 60-month term that begins on the service-ready date, subject to contractual service-start conditions. Separately, Quanome also agreed to purchase a further 32 GPU servers on September 29, 2026, bringing the total under purchase agreements to 64.

 

Management anticipates initial service revenue from Quanome’s subsidiary, XDT, to commence in the second or third quarter of fiscal 2027, subject to successful deployment and satisfaction of the service-start conditions. XDT is the commercial focus of Quanome’s Quantum and AI Systems stream.

 

On November 9, 2026, Quanome announced advancements within its Quantum Life Sciences – Molecular Discovery stream, reporting an all-stock agreement to acquire approximately 5% of QAI Labs at closing. QAI Labs is an independent life sciences technology company developing NOVA-3, a platform that combines AI-assisted molecular design with laboratory testing to identify antibodies that could be developed into treatments for disease.

 

Advanced Nuclear and Quantum-Safe Cybersecurity complete Quanome’s four strategic areas of focus, through which the Company aims to build long-term growth and shareholder value.

 

Ends.

 

Forward-looking statements

 

This release contains forward-looking statements. Statements about infrastructure deployment, service commencement, expected revenue timing, completion of the QAI Labs investment and long-term growth reflect management’s current expectations. Actual outcomes may differ materially depending on equipment delivery, satisfaction of contractual conditions, customer and supplier performance, financing availability and other risks described in Quanome’s most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2026 and any subsequent documents filed with the U.S. Securities and Exchange Commission.

 

About Quanome

 

Quanome Technologies, Inc. (Nasdaq: QNME) is a U.S.-based company headquartered in New York, New York. Quanome is building capabilities and an investment portfolio at the intersection of quantum technologies, artificial intelligence, advanced simulation and intelligent systems. Through internal development, strategic relationships and selected investments, Quanome seeks to translate emerging science into real-world applications across life sciences, cybersecurity, advanced materials, energy, financial systems and other industries shaped by complex computational challenges. For more information, visit www.quanometech.com.

 

Media and investor contact

 

Lauren Callie | investor@quanometech.com

 

Filing Exhibits & Attachments

4 documents

Keep reading